Nerlynx
Active substance: neratinib
neratinib
Centralised EU authorisationActive
Marketing holder: Pierre Fabre Medicament
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-d813-7d03-be6b-09718331d733,01a12097-da0f-7130-af12-d3508e02fb04;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004030
- Registration status
- Active
- ATC code
- L01EH02
Sources
- product · EMA · EMEA/H/C/004030 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004030 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004030 · Verified 2026-10-09